The use of ticagrelor in acute coronary syndromes [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2013; 41(1): 12-16

The use of ticagrelor in acute coronary syndromes

Sinan Aydoğdu1, Özlem Özcan Çelebi2
1Turkey High Specialization Hospital Cardiology Clinic, Ankara, Turkey
2Medicine International Ankara Hospital, Cardiology Clinic, Ankara, Turkey

Acute coronary syndrome plays a major role in the treatment of acute coronary syndrome. New agents have been developed and introduced into clinical practice while dual antiplattelet therapy has been limited with clopidogrel until recently. In this review we summarize the efficacy of ticagrelor, a new antiplatelet agent.


How to cite this article
Sinan Aydoğdu, Özlem Özcan Çelebi. The use of ticagrelor in acute coronary syndromes. Turk Kardiyol Dern Ars. 2013; 41(1): 12-16

Corresponding Author: Sinan Aydoğdu, Türkiye
© Copyright 2020 Archives of the Turkish Society of Cardiology
LookUs & Online Makale